Monday, April 16, 2007
Position Updates: ARWR
Via Briefing:
7:04AM Arrowhead Research: Calando Pharma announces preclinical efficacy and safety data of targeted, systemic delivery of siRNA at AACR meeting (ARWR) 5.30 : Calando Pharmaceuticals, a majority-owned subsidiary of ARWR, announces it presented positive results of preclinical efficacy testing in mice using multiple, systemic dosing with Calando's lead siRNA therapeutic candidate CALAA-01, a nanoparticle containing non-chemically modified siRNA and a transferrin protein targeting agent at the American Association for Cancer Research (AACR) annual meeting on April 17, 2007 in Los Angeles, California.
Comments:
<< Home
Thanks yet again on ARWR Broker!
Enjoying IIG as well as well as all the others. Unbelieveable.
Christmas never seems to end at Fly on WallStreet.
Enjoying IIG as well as well as all the others. Unbelieveable.
Christmas never seems to end at Fly on WallStreet.
Well played.
BTW, I've only been following your blog for a couple of weeks. Do you give sell recs as well as buys?
-DT
BTW, I've only been following your blog for a couple of weeks. Do you give sell recs as well as buys?
-DT
Fuck blogging, I don't feel like starting over!
I'm thinking of selling my site to shortdabull in exchange for some more MVIS shares.
I'm thinking of selling my site to shortdabull in exchange for some more MVIS shares.
BWLD shorts are getting their arms ripped off. MVIS shorts are about to get squeezed. Broker is off supervising Mexicans damming up his house from water, all the while counting his fucking money. What else could be better?
Post a Comment
<< Home